Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study

[1] Wingerchuk DM(1999)The clinical course of neuromyelitis optica (Devic’s syndrome) Neurology 53 1107-1114

[2] Hogancamp WF(2005)IgG marker of optic-spinal multiple sclerosis binds the aquaporin-4 water channel J Exp Med 202 433-437

[3] O’Brien PC(2008)NMO-IgG predicts the outcome of recurrent optic neuritis Neurology 70 2197-2200

[4] Weinshenker BG(2006)Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis Ann Neurol 59 566-569

[5] Lennon VA(2008)Antibody to aquaporin-4 in the long term course of neuromyelitis optica Brain 131 3072-3080

[6] Kryzer TJ(2008)Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica Mult Scler 14 1061-1067

[7] Pittock SJ(2009)Neuromyelitis optica: passive transfer to rats by human immunoglobulin Biochem Biophys Res Commun 386 623-627

[8] Verkman AS(2009)Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo Ann Neurol 66 630-643

[9] Hinson SR(2009)Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica Ann Neurol 66 617-629

[10] Matiello M(2010)Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice Brain 133 349-361

[1] Wingerchuk DM(1999)The clinical course of neuromyelitis optica (Devic’s syndrome) Neurology 53 1107-1114

[2] Hogancamp WF(2005)IgG marker of optic-spinal multiple sclerosis binds the aquaporin-4 water channel J Exp Med 202 433-437

[3] O’Brien PC(2008)NMO-IgG predicts the outcome of recurrent optic neuritis Neurology 70 2197-2200

[4] Weinshenker BG(2006)Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis Ann Neurol 59 566-569

[5] Lennon VA(2008)Antibody to aquaporin-4 in the long term course of neuromyelitis optica Brain 131 3072-3080

[6] Kryzer TJ(2008)Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica Mult Scler 14 1061-1067

[7] Pittock SJ(2009)Neuromyelitis optica: passive transfer to rats by human immunoglobulin Biochem Biophys Res Commun 386 623-627

[8] Verkman AS(2009)Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo Ann Neurol 66 630-643

[9] Hinson SR(2009)Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica Ann Neurol 66 617-629

[10] Matiello M(2010)Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice Brain 133 349-361